Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 21 studies | 34% ± 12% | |
astrocyte | 15 studies | 41% ± 18% | |
fibroblast | 9 studies | 29% ± 10% | |
adipocyte | 8 studies | 25% ± 6% | |
GABAergic neuron | 7 studies | 41% ± 20% | |
epithelial cell | 7 studies | 26% ± 12% | |
oligodendrocyte precursor cell | 7 studies | 27% ± 10% | |
pericyte | 7 studies | 40% ± 16% | |
neuron | 6 studies | 32% ± 12% | |
interneuron | 6 studies | 33% ± 14% | |
smooth muscle cell | 6 studies | 27% ± 9% | |
endothelial cell of lymphatic vessel | 5 studies | 28% ± 6% | |
glutamatergic neuron | 5 studies | 53% ± 22% | |
oligodendrocyte | 5 studies | 26% ± 9% | |
goblet cell | 5 studies | 33% ± 20% | |
glial cell | 4 studies | 32% ± 11% | |
retinal ganglion cell | 4 studies | 28% ± 7% | |
endothelial cell of artery | 4 studies | 21% ± 5% | |
basal cell | 4 studies | 31% ± 21% | |
granule cell | 3 studies | 29% ± 5% | |
vein endothelial cell | 3 studies | 31% ± 13% | |
ciliated cell | 3 studies | 18% ± 1% | |
rod bipolar cell | 3 studies | 34% ± 17% | |
endothelial cell of vascular tree | 3 studies | 32% ± 19% | |
ependymal cell | 3 studies | 30% ± 14% | |
type I pneumocyte | 3 studies | 23% ± 7% | |
mesothelial cell | 3 studies | 23% ± 4% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 38% ± 13% | |
renal alpha-intercalated cell | 3 studies | 19% ± 4% | |
renal principal cell | 3 studies | 46% ± 16% | |
mucus secreting cell | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1498.83 | 962 / 966 | 98% | 14.82 | 516 / 527 |
stomach | 100% | 1024.75 | 358 / 359 | 97% | 17.75 | 277 / 286 |
esophagus | 98% | 901.70 | 1411 / 1445 | 99% | 24.76 | 181 / 183 |
skin | 100% | 1790.53 | 1804 / 1809 | 93% | 16.27 | 437 / 472 |
ovary | 99% | 810.85 | 178 / 180 | 89% | 12.28 | 384 / 430 |
breast | 100% | 1216.12 | 458 / 459 | 87% | 10.68 | 978 / 1118 |
brain | 92% | 800.93 | 2428 / 2642 | 92% | 9.79 | 647 / 705 |
lung | 99% | 1038.59 | 575 / 578 | 84% | 11.98 | 965 / 1155 |
kidney | 100% | 1154.47 | 89 / 89 | 83% | 10.81 | 745 / 901 |
bladder | 100% | 846.90 | 21 / 21 | 82% | 9.39 | 414 / 504 |
thymus | 100% | 1771.24 | 652 / 653 | 81% | 17.52 | 490 / 605 |
uterus | 100% | 1389.18 | 170 / 170 | 78% | 9.68 | 358 / 459 |
pancreas | 79% | 337.41 | 258 / 328 | 90% | 15.94 | 161 / 178 |
prostate | 96% | 593.97 | 235 / 245 | 73% | 5.31 | 367 / 502 |
blood vessel | 100% | 2127.67 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1644.02 | 1203 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 61% | 230.08 | 157 / 258 | 36% | 2.28 | 83 / 230 |
heart | 93% | 716.19 | 798 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 6.19 | 61 / 80 |
tonsil | 0% | 0 | 0 / 0 | 76% | 8.48 | 34 / 45 |
muscle | 38% | 137.63 | 307 / 803 | 0% | 0 | 0 / 0 |
liver | 4% | 12.00 | 8 / 226 | 26% | 1.92 | 105 / 406 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.29 | 2 / 29 |
spleen | 2% | 4.74 | 4 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005829 | Cellular component | cytosol |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ASAP2 |
Protein name | Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
Synonyms | KIAA0400 DDEF2 |
Description | FUNCTION: Activates the small GTPases ARF1, ARF5 and ARF6. Regulates the formation of post-Golgi vesicles and modulates constitutive secretion. Modulates phagocytosis mediated by Fc gamma receptor and ARF6. Modulates PXN recruitment to focal contacts and cell migration. . |
Accessions | ENST00000281419.8 [O43150-1] A0A286YFG8 ENST00000641030.1 O43150 ENST00000315273.4 [O43150-2] |